Lineage Cell Therapeutics Inc (LCTX)
1.02
+0.02
(+2.00%)
USD |
NYAM |
Jun 03, 16:00
1.02
0.00 (0.00%)
After-Hours: 20:00
Lineage Cell Therapeutics Max Drawdown (5Y): 90.06% for May 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
May 31, 2024 | 90.06% |
April 30, 2024 | 90.06% |
March 31, 2024 | 90.06% |
February 29, 2024 | 90.06% |
January 31, 2024 | 90.06% |
December 31, 2023 | 90.06% |
November 30, 2023 | 90.06% |
October 31, 2023 | 90.06% |
September 30, 2023 | 90.06% |
August 31, 2023 | 90.06% |
July 31, 2023 | 90.06% |
June 30, 2023 | 90.06% |
May 31, 2023 | 90.06% |
April 30, 2023 | 90.06% |
March 31, 2023 | 90.06% |
February 28, 2023 | 90.06% |
January 31, 2023 | 90.06% |
December 31, 2022 | 90.06% |
November 30, 2022 | 90.06% |
October 31, 2022 | 90.06% |
September 30, 2022 | 90.06% |
August 31, 2022 | 90.06% |
July 31, 2022 | 90.06% |
June 30, 2022 | 90.06% |
May 31, 2022 | 90.06% |
Date | Value |
---|---|
April 30, 2022 | 90.06% |
March 31, 2022 | 90.06% |
February 28, 2022 | 90.06% |
January 31, 2022 | 90.06% |
December 31, 2021 | 90.06% |
November 30, 2021 | 90.06% |
October 31, 2021 | 90.06% |
September 30, 2021 | 90.06% |
August 31, 2021 | 90.06% |
July 31, 2021 | 90.06% |
June 30, 2021 | 90.06% |
May 31, 2021 | 90.06% |
April 30, 2021 | 90.06% |
March 31, 2021 | 90.06% |
February 28, 2021 | 90.06% |
January 31, 2021 | 90.06% |
December 31, 2020 | 90.06% |
November 30, 2020 | 90.06% |
October 31, 2020 | 90.06% |
September 30, 2020 | 90.06% |
August 31, 2020 | 90.06% |
July 31, 2020 | 90.06% |
June 30, 2020 | 90.06% |
May 31, 2020 | 90.06% |
April 30, 2020 | 90.06% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
84.17%
Minimum
Jun 2019
90.06%
Maximum
Dec 2019
89.54%
Average
90.06%
Median
Dec 2019
Max Drawdown (5Y) Benchmarks
Acumen Pharmaceuticals Inc | -- |
Sarepta Therapeutics Inc | 64.93% |
CEL-SCI Corp | 96.13% |
AIM ImmunoTech Inc | 99.76% |
IGC Pharma Inc | 97.77% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -19.84 |
Beta (5Y) | 1.309 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 65.81% |
Historical Sharpe Ratio (5Y) | -0.0289 |
Historical Sortino (5Y) | -0.0565 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 23.81% |